Bioventus DSO Ratio 2011-2026 | BVS

Annual DSO Ratio Bioventus

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
82.1	79.6	92.3	93.1	52.9	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
93.1	52.9	80

Quarterly DSO Ratio Bioventus

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
86.5	77.4	88.4	85.1	79.3	84	87.8	79.3	97.7	-	97.6	85.3	95	-	86.9	79.6	99.2	-	93.8	139	51.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
139	51.2	88.5

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Biodesix BDSX	41.7	$ 15.31	4.22 %	$ 1.99 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Lantheus Holdings LNTH	80.5	$ 74.11	-2.15 %	$ 5 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	50.7	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	101	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Medpace Holdings MEDP	50.4	$ 463.46	1.43 %	$ 13.4 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	65	$ 159.84	1.16 %	$ 7.92 B	USA
IQVIA Holdings IQV	73.9	$ 165.65	-0.81 %	$ 28.5 B	USA
Myriad Genetics MYGN	52.3	$ 4.67	0.11 %	$ 432 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
National Research Corporation NRC	29.4	$ 17.26	-1.46 %	$ 386 M	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	63.7	$ 1.22	-16.44 %	$ 6.64 M	USA
Mettler-Toledo International MTD	66.4	$ 1 261.71	1.72 %	$ 26 B	Schweiz
Interpace Biosciences IDXG	53.1	$ 1.71	0.73 %	$ 7.5 M	USA
Illumina ILMN	61.3	$ 125.17	1.11 %	$ 19.9 B	USA
Pacific Biosciences of California PACB	71.8	$ 1.38	-1.08 %	$ 414 M	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Precipio PRPO	28.1	$ 27.01	0.3 %	$ 35.1 M	USA
Personalis PSNL	55.8	$ 7.67	0.72 %	$ 454 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 266.56	0.81 %	$ 22.2 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
RadNet RDNT	34.5	$ 59.22	-4.09 %	$ 4.45 B	USA
ENDRA Life Sciences NDRA	7.11	$ 3.49	0.29 %	$ 1.87 M	USA
NeoGenomics NEO	77.7	$ 7.87	-2.82 %	$ 1.01 B	USA
Natera NTRA	81.5	$ 193.75	-3.17 %	$ 19.1 B	USA
Senseonics Holdings SENS	10.3	$ 6.63	0.08 %	$ 277 M	USA
Sotera Health Company SHC	43.9	$ 13.82	-0.43 %	$ 3.92 B	USA
CareDx, Inc CDNA	51.5	$ 17.65	0.51 %	$ 941 M	USA
Soleno Therapeutics SLNO	27	$ 30.84	-2.77 %	$ 1.57 B	USA
OPKO Health OPK	240	$ 1.14	-1.3 %	$ 791 M	USA
Castle Biosciences CSTL	49.2	$ 25.23	-2.02 %	$ 701 M	USA
DarioHealth Corp. DRIO	56.7	$ 8.05	7.27 %	$ 32.1 M	Israel
DexCom DXCM	87	$ 66.28	0.51 %	$ 25.9 B	USA
Neuronetics STIM	48.7	$ 1.47	-8.12 %	$ 96.9 M	USA
Exact Sciences Corporation EXAS	30.8	$ 104.91	-	$ 19.8 B	USA